Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

2020; Elsevier BV; Volume: 55; Issue: 6 Linguagem: Inglês

10.1016/j.ijantimicag.2020.105969

ISSN

1872-7913

Autores

Marissa Bolson Serafin, Angelita Bottega, Vitória Segabinazzi Foletto, Taciéli F. da Rosa, Andreas Hörner, Rosmari Hörner,

Tópico(s)

Vitamin C and Antioxidants Research

Resumo

Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.

Referência(s)